IRIDEX
Company   Investors   Events   News   Careers   Search
Sales: 
Support: (800) 388-4747
  • Home
  • Products
    • Lasers
      • IQ 532™
      • IQ 577™
      • IQ 810™
      • Additional Lasers
    • Delivery Devices
    • Retina Consumables
      • EndoProbe Handpieces
      • Consumables
      • DioPexy™ Probe
    • Glaucoma Consumables
    • Veterinary
    • ENT
  • MicroPulse™
  • Physician Education
    • Glaucoma
      • TSCPC G-Probe
      • Trabeculoplasty (MLT)
    • Retina
      • Central Serous Chorioretinopathy
      • Diabetic Macular Edema
      • ME due to RVOs
      • Vitreoretinal Surgery
    • Clinical Library
  • Patient Education
    • Treat My DME
    • Treat My Glaucoma
  • Contact
    • Contact Us
    • Ask A Question
    • Schedule A Demo
    • Request A Quote
    • Order EndoProbe®
    • International Distributors
HOME > Products > Glaucoma Consumables > G-Probe

G-Probe™ - Control Uncontrolled Glaucoma

g probe

G-Probe Glaucoma Device Offers an Office-based, Non-invasive Surgical Solution

Transscleral cyclophotocoagulation (TSCPC) using the G-Probe glaucoma device is a long-term, effective intraocular pressure (IOP) lowering procedure for many types of glaucoma patients.1-3 Patients with refractory glaucoma and those with good visual acuity can benefit from TSCPC using the G-Probe.

Download Brochure
Ask A Question
Schedule Demo
Request A Quote
  • Overview
  • Clinical
  • Compatible Products
  • Model Numbers
  • Testimonials

G-Probe glaucoma device performs transscleral cyclophotocoagulation (TSCPC) to lower IOP through selective ablation of the ciliary processes. This simple, yet effective repeatable procedure can be performed in the office, operating room, or in conjunction with other procedures, like cataract surgery.

 

G-Probe treatment   G-Probe placement   G-Probe application

Placement

Hold the G-Probe™ parallel to the visual axis with the shorter edge of the footplate firmly between the anterior border and the middle of the limbus. Laser delivery is transscleral.

 

Application

Successive applications are spaced one-half the width of the G-Probe footplate apart by aligning a side of the probe over the indented center of the adjacent application.

 

Treatment

Administer 18-21 laser applications per treatment session over 270° (three quadrants, six or seven applications per quadrant), usually omitting the temporal quadrant.

G-Probe treatment parameters are suggested by IRIDEX and are based on recommendations by experienced clinicians. Ultimately, it is the physician’s responsibility to determine appropriate treatment parameters for each case.

Iris Color

Power

Duration

Energy per Application

Dark Brown
1250 mW
4000 ms 5.00 joules
All other
1500 mW
3500 ms
5.25 joules

This array of treatment parameters has been called the “slow coagulation” technique and has proven effective for most eyes.

pdf  Download the G-Probe IFU


 

Revisiting TSCPC as an Option
Ophthalmology Today

Procedure has ability to lower IOP, preserve vision similar to trabeculectomy and tube shunts

pdf Download Now

 

 

Transscleral cyclophotocoagulation effective as early glaucoma treatment

Although typically a last line of defense, the treatment has shown to be beneficial early in the glaucoma surgical treatment paradigm.
Parag Parekh, MD

pdf Download Now

 


 

Diode Laser Cyclophotocoagulation
Glaucoma Today

Technique and results.

pdf Download Now

 


 

Reconsidering Transscleral Cyclophotocoagulation
Glaucoma Today

pdf Download Now

 


 

The Benefits of Transscleral Cyclophotocoagulation
Glaucoma Today

This viable alternative to trabeculectomy should be considered in more moderate to severe glaucoma cases

pdf Download Now

 


 
 

Article G-Probe vs. ECP
Glaucoma Today

pdf Download Now

Compatible Products

810   SLX
  SL Laser

IQ 810™ laser

 

OcuLight® SLx laser console

 

OcuLight® SL laser console

Model Numbers

Standard Handle 2.5" (6.4 cm)   11256
kammer

You can really consider TSCPC in almost all glaucoma situation, even malignant glaucoma. It is not just relegated to end-stage treatment anymore.

Dr. Jeffrey Kammer | Nashville, TN | Vanderbilt Eye Institute

kammer

TSCPC is a surgery that can be done before or after any other surgery. It is very versatile from that standpoint.

Dr. Nathan Radcliffe | New York, NY | Weill Cornell Medical College

Dr. Steven Vold

Recovery with TSCPC is much more rapid and the postoperative care much less involved than with someone who has had an incisional glaucoma case in a surgical center.

Dr. Steven Vold | Springdale, AR | Vold Vision, PLLC

  1. Wilensky JT, Kammer J. Long-term visual outcome of transscleral laser cyclotherapy in eyes with ambulatory vision. Ophthalmology. 2004;111(7):1389-1392.
  2. Egbert PR, Fiadoyor S, Budenz DL, et al. Diode laser transscleral photocoagulation as a primary surgical treatment for primary open angle glaucoma. Arch Ophthalmol. 2001;119:345-350.
  3. Roctchford AP, Jayasawi R, Madhusuhan S, et al. Transscleral diode laser cycloablation in patients with good vision. Br J Ophthalmol. 2010;94(9):1130-1183.
logo aa0 logo ags logo ascrs logo asrs logo esrs0 logo euretina

 Products

Lasers
Delivery Devices
Retina Consumables
Glaucoma Device

Resources

Physician Information
Patient Information
MicroPulse Forum
Clinical Library

 

About IRIDEX

Overview
News
Events
Contact Us

Company

Investors
Offices/Contact
Careers

twitter facebook linkedin youtuber
Copyright ©2003-2013 by IRIDEX Corporation
Terms Of Use | Privacy Statement